UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis

Total Page:16

File Type:pdf, Size:1020Kb

UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis Published OnlineFirst February 6, 2020; DOI: 10.1158/0008-5472.CAN-19-1647 CANCER RESEARCH | MOLECULAR CELL BIOLOGY UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis Xi Qiao1,2,3, Ying Liu4,5, Maria Llamazares Prada6, Aravind K. Mohan7, Abhishekh Gupta8, Alok Jaiswal8, Mukund Sharma1,2,3, Joni Merisaari1,2,3, Heidi M. Haikala9, Kati Talvinen2, Laxman Yetukuri1,8, Joanna W. Pylvan€ ainen€ 10, Juha Klefstrom€ 9, Pauliina Kronqvist2, Annika Meinander7, Tero Aittokallio8,11, Ville Hietakangas4,5, Martin Eilers6, and Jukka Westermarck1,2 ABSTRACT ◥ For maximal oncogenic activity, cellular MYC protein levels need Graphical Abstract: http://cancerres.aacrjournals.org/content/ to be tightly controlled so that they do not induce apoptosis. Here, canres/80/7/1414/F1.large.jpg. we show how ubiquitin ligase UBR5 functions as a molecular rheostat to prevent excess accumulation of MYC protein. UBR5 ubiquitinates MYC and its effects on MYC protein stability are independent of FBXW7. Silencing of endogenous UBR5 induced MYC transcription MYC protein expression and regulated MYC target genes. Consis- Apoptosis tent with the tumor suppressor function of UBR5 (HYD) in Priming to drug-induced Drosophila, HYD suppressed dMYC-dependent overgrowth of apoptosis wing imaginal discs. In contrast, in cancer cells, UBR5 suppressed Cancer cell UBR5 low MYC-dependent priming to therapy-induced apoptosis. Of direct proliferation fi Normal cell cancer relevance, MYC and UBR5 genes were coampli ed in MYC- UBR5 high proliferation driven human cancers. Functionally, UBR5 suppressed MYC- MYC protein levels Quiescence mediated apoptosis in p53-mutant breast cancer cells with UBR5/MYC coamplification. Furthermore, single-cell immunoflu- UBR5 orescence analysis demonstrated reciprocal expression of UBR5 and 8q22.33 UBR5 MYC in human basal-type breast cancer tissues. In summary, UBR5 is a novel MYC ubiquitin ligase and an endogenous rheostat for MYC Breast cancer fi chemotherapy MYC activity. In MYC-ampli ed, and p53-mutant breast cancer 8q24.21 insensitivity cells, UBR5 has an important role in suppressing MYC-mediated apoptosis priming and in protection from drug-induced apoptosis. MYC Chr. 8 mRNA Protein Significance: These findings identify UBR5 as a novel MYC Coamplification of UBR5 with MYC is a cancer cell intrinsic mechanism regulator, the inactivation of which could be very important for to dampen MYC-mediated apoptosis in response to chemotherapy. understanding of MYC dysregulation on cancer cells. Introduction MYC regulates numerous physiologic and pathologic processes. Crit- ically, distinct protein expression levels dictate MYC's biological Emerging notion of overall poor concordance between gene ampli- output in vitro and in vivo (2–5). MYC protein levels are tightly fications and corresponding protein expression levels in cancer (1) regulated posttranslationally by phosphorylation, and by ubiquitin- highlights the need for better understanding of how protein expression mediated degradation (6–10). Especially in cancers, MYC is a classic levels are regulated at posttranslational levels. The transcription factor example of an oncoprotein, whose overexpression at protein level do 1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Note: Supplementary data for this article are available at Cancer Research Turku, Finland. 2Institute of Biomedicine, University of Turku, Turku, Fin- Online (http://cancerres.aacrjournals.org/). land. 3TuDMM Doctoral Programme, University of Turku, Turku, Finland. Y. Liu and M.L. Prada contributed equally to this article. 4Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland. 5Institute of Biotechnology, University of Helsinki, Hel- Current address for M.L. Prada: BioMed X Innovation Center, Heidelberg, sinki, Finland. 6Theodor Boveri Institute and Comprehensive Cancer Center, Germany. Mainfranken, Biocenter, University of Wurzburg,€ Wurzburg,€ Germany. Corresponding Author: Jukka Westermarck, Turku Bioscience Centre, 7Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Tykistokatu€ 6A, Turku 20520, Finland. Phone: 358-29-450 2880; E-mail: Turku, Finland. 8Institute for Molecular Medicine Finland (FIMM), University jukka.westermarck@bioscience.fi of Helsinki, Helsinki, Finland. 9Research Programs Unit/Translational Can- cer Medicine & HiLIFE, University of Helsinki, Helsinki, Finland. 10Turku Cancer Res 2020;80:1414–27 BioImaging, University of Turku and Åbo Akademi University, Turku, Fin- doi: 10.1158/0008-5472.CAN-19-1647 land. 11Department of Mathematics and Statistics, University of Turku, Turku, Finland. Ó2020 American Association for Cancer Research. AACRJournals.org | 1414 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2020 American Association for Cancer Research. Published OnlineFirst February 6, 2020; DOI: 10.1158/0008-5472.CAN-19-1647 Ubiquitin Ligase UBR5 Controls MYC in Development and Cancer not match neither with the extent of mRNA overexpression nor with Institut fur€ Rechtsmedizin, Universit€at Wurzburg€ (Wurzburg,€ Ger- the frequency of genetic amplifications (7, 11). many). All the cell lines were tested negative for Mycoplasma during In addition to cell culture and mouse models (3, 4, 8, 12, 13), the role the period of this study. Drosophila S2 cells were cultured in Schneider of MYC has been widely studied in Drosophila, where the conserved Drosophila Medium (Thermo Fisher Scientific). All growth mediums homolog of MYC, dMYC regulates tissue growth and animal were supplemented with 10% heat-inactivated FBS (Gibco), 2 mmol/L size (14, 15). In particular, overexpression of dMYC induces growth L-glutamine, and penicillin (50 U/mL)/streptomycin (50 mg/mL). of cells of the imaginal discs, which are the organs giving rise to wings GFP-UBR5, GFP-UBR5-DHECT, Flag-UBR5, and Flag-UBR5- in adult fly (14). Importantly, dMYC can complement mammalian DHECT were kind gifts from Darren Saunders & Charles MYC in vivo (13) implying high degree of functional conservation. In Watts (28, 29). V5-MYC, V5-MYCT58A and have been described humans, MYC is a master regulator of malignant growth. However, previously (10). Flag-MYC plasmids and HA-MYC (1–262) were MYC protein levels exceeding the optimal proliferation promoting from Prof. Bruno Amati (European Institute of Oncology, Milan, levels primes both normal and cancer cells to apoptosis (2, 3, 5, 12). The Italy). HA-MYC-WT and HA-MYC mutants were kind gifts from principle of MYC-mediated apoptosis priming was originally revealed Prof. William P. Tansey (Vanderbilt University School of Medicine, by findings showing that highly overexpressed transgenic MYC initi- Nashville, TN). HA-ubiqiuitin was a kind gift from Prof. Lea Sistonen ates both proliferation and apoptosis programs in pancreatic islet cells. (Åbo Akademi University, Turku, Finland). Plasmids were transfected However, MYC overexpression was capable to drive tumorigenesis with Lipofectamine 2000 Transfection Reagent (Thermo Fisher Sci- only in the context of efficient apoptosis suppression (12). More entific) according to the manufacturer's instructions. After 48-hour recently, the in vivo importance of MYC expression levels in defining transfection, cell lysate was collected. Small interfering RNA (siRNA) the balance between proliferation and apoptosis was validated by allelic transfections were performed with Oligofectamine Transfection series of inducible MYC expression (3). In addition to spontaneous Reagent (Thermo Fisher Scientific) following to the manufacturer's apoptosis, high MYC levels prime tumor cells to apoptosis induction protocol. Three days after transfections, cells were harvested for by drugs that interfere with replication and cell division, such as analysis. siRNA target sequences are in supplementary table 1. For topoisomerase inhibitors or taxanes (2, 16, 17). Indeed, MYC is an double-stranded RNA (dsRNA)-mediated RNAi in Drosophila S2 important determinant of in vivo cell survival both during develop- cells, the DNA fragment of hyd was amplified with primers flanked ment and in response to cancer therapy (4). However, how MYC by T7 promoter, and dsRNA was produced using the TranscriptAid T7 protein levels are controlled endogenously to maintain an optimal High Yield Transcription Kit (Thermo Fisher Scientific). To knock MYC balance is incompletely understood. down Hyd, S2 cells were cultured with 5 mg/mL dsRNA for 120 hours. UBR5 (Ubiquitin protein ligase E3 component n-recognin 5) is an evolutionary conserved E3 ubiquitin ligase that destabilizes proteins Immunoblotting and immunoprecipitation with N-terminal recognition sequences exposed by proteolytic cleav- The following antibodies were used for Western blot analysis: UBR5 age (18, 19). Recently, UBR5 has been shown to target substrates also (sc-515494, Santa Cruz Biotechnology), MYC (ab32072, Abcam), through other recognition mechanisms than N-terminal recogni- cleaved PARP (ab32064, Abcam), BIM (2933, Cell Signaling Tech- tion (20). UBR5 is essential for mammalian development (21), and nology), vinculin (sc-25336, Santa Cruz Biotechnology), GAPDH has been linked to both protumorigenic and tumor-suppressing (5G4-6C5, HyTest Ltd), HA (3724, Cell Signaling Technology), Flag activities (19, 21–23). However, the mechanism by which UBR5 would (F3165, Sigma), GFP (sc-9996, Santa Cruz Biotechnology), GST promote tumor growth are unclear. It is also unclear how UBR5 may (sc-138, Santa Cruz Biotechnology),
Recommended publications
  • The Cross-Talk Between Methylation and Phosphorylation in Lymphoid-Specific Helicase Drives Cancer Stem-Like Properties
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans ARTICLE OPEN The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties Na Liu1,2,3, Rui Yang1,2, Ying Shi1,2, Ling Chen1,2, Yating Liu1,2, Zuli Wang1,2, Shouping Liu1,2, Lianlian Ouyang4, Haiyan Wang1,2, Weiwei Lai1,2, Chao Mao1,2, Min Wang1,2, Yan Cheng5, Shuang Liu4, Xiang Wang6, Hu Zhou7, Ya Cao1,2, Desheng Xiao1 and Yongguang Tao1,2,6 Posttranslational modifications (PTMs) of proteins, including chromatin modifiers, play crucial roles in the dynamic alteration of various protein properties and functions including stem-cell properties. However, the roles of Lymphoid-specific helicase (LSH), a DNA methylation modifier, in modulating stem-like properties in cancer are still not clearly clarified. Therefore, exploring PTMs modulation of LSH activity will be of great significance to further understand the function and activity of LSH. Here, we demonstrate that LSH is capable to undergo PTMs, including methylation and phosphorylation. The arginine methyltransferase PRMT5 can methylate LSH at R309 residue, meanwhile, LSH could as well be phosphorylated by MAPK1 kinase at S503 residue. We further show that the accumulation of phosphorylation of LSH at S503 site exhibits downregulation of LSH methylation at R309 residue, which eventually promoting stem-like properties in lung cancer. Whereas, phosphorylation-deficient LSH S503A mutant promotes the accumulation of LSH methylation at R309 residue and attenuates stem-like properties, indicating the critical roles of LSH PTMs in modulating stem-like properties. Thus, our study highlights the importance of the crosstalk between LSH PTMs in determining its activity and function in lung cancer stem-cell maintenance.
    [Show full text]
  • A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Takafumi Tasaki,1 Lubbertus C
    MOLECULAR AND CELLULAR BIOLOGY, Aug. 2005, p. 7120–7136 Vol. 25, No. 16 0270-7306/05/$08.00ϩ0 doi:10.1128/MCB.25.16.7120–7136.2005 Copyright © 2005, American Society for Microbiology. All Rights Reserved. A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Takafumi Tasaki,1 Lubbertus C. F. Mulder,2 Akihiro Iwamatsu,3 Min Jae Lee,1 Ilia V. Davydov,4† Alexander Varshavsky,4 Mark Muesing,2 and Yong Tae Kwon1* Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 152611; Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 100162; Protein Research Network, Inc., Yokohama, Kanagawa 236-0004, Japan3; and Division of Biology, California Institute of Technology, Pasadena, California 911254 Received 15 March 2005/Returned for modification 27 April 2005/Accepted 13 May 2005 A subset of proteins targeted by the N-end rule pathway bear degradation signals called N-degrons, whose determinants include destabilizing N-terminal residues. Our previous work identified mouse UBR1 and UBR2 as E3 ubiquitin ligases that recognize N-degrons. Such E3s are called N-recognins. We report here that while double-mutant UBR1؊/؊ UBR2؊/؊ mice die as early embryos, the rescued UBR1؊/؊ UBR2؊/؊ fibroblasts still retain the N-end rule pathway, albeit of lower activity than that of wild-type fibroblasts. An affinity assay for proteins that bind to destabilizing N-terminal residues has identified, in addition to UBR1 and UBR2, a huge (570 kDa) mouse protein, termed UBR4, and also the 300-kDa UBR5, a previously characterized mammalian E3 known as EDD/hHYD.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Functional Diversification of the Nleg Effector Family in Enterohemorrhagic Escherichia Coli
    Functional diversification of the NleG effector family in enterohemorrhagic Escherichia coli Dylan Valleaua, Dustin J. Littleb, Dominika Borekc,d, Tatiana Skarinaa, Andrew T. Quailea, Rosa Di Leoa, Scott Houlistone,f, Alexander Lemake,f, Cheryl H. Arrowsmithe,f, Brian K. Coombesb, and Alexei Savchenkoa,g,1 aDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada; bDepartment of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4K1, Canada; cDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390; dDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390; ePrincess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2M9, Canada; fDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; and gDepartment of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada Edited by Ralph R. Isberg, Howard Hughes Medical Institute and Tufts University School of Medicine, Boston, MA, and approved August 15, 2018 (receivedfor review November 6, 2017) The pathogenic strategy of Escherichia coli and many other gram- chains. Depending on the length and nature of the polyubiquitin negative pathogens relies on the translocation of a specific set of chain, it posttranslationally regulates the target protein’s locali- proteins, called effectors, into the eukaryotic host cell during in- zation, activation, or degradation. Ubiquitination is a multistep fection. These effectors act in concert to modulate host cell pro- process which begins with the ubiquitin-activating enzyme (E1) cesses in favor of the invading pathogen. Injected by the type III using ATP to “charge” ubiquitin, covalently binding the ubiquitin secretion system (T3SS), the effector arsenal of enterohemorrhagic C terminus by a thioester linkage.
    [Show full text]
  • Chronic Exposure of Humans to High Level Natural Background Radiation Leads to Robust Expression of Protective Stress Response Proteins S
    www.nature.com/scientificreports OPEN Chronic exposure of humans to high level natural background radiation leads to robust expression of protective stress response proteins S. Nishad1,2, Pankaj Kumar Chauhan3, R. Sowdhamini3 & Anu Ghosh1,2* Understanding exposures to low doses of ionizing radiation are relevant since most environmental, diagnostic radiology and occupational exposures lie in this region. However, the molecular mechanisms that drive cellular responses at these doses, and the subsequent health outcomes, remain unclear. A local monazite-rich high level natural radiation area (HLNRA) in the state of Kerala on the south-west coast of Indian subcontinent show radiation doses extending from ≤ 1 to ≥ 45 mGy/y and thus, serve as a model resource to understand low dose mechanisms directly on healthy humans. We performed quantitative discovery proteomics based on multiplexed isobaric tags (iTRAQ) coupled with LC–MS/MS on human peripheral blood mononuclear cells from HLNRA individuals. Several proteins involved in diverse biological processes such as DNA repair, RNA processing, chromatin modifcations and cytoskeletal organization showed distinct expression in HLNRA individuals, suggestive of both recovery and adaptation to low dose radiation. In protein–protein interaction (PPI) networks, YWHAZ (14-3-3ζ) emerged as the top-most hub protein that may direct phosphorylation driven pro- survival cellular processes against radiation stress. PPI networks also identifed an integral role for the cytoskeletal protein ACTB, signaling protein PRKACA; and the molecular chaperone HSPA8. The data will allow better integration of radiation biology and epidemiology for risk assessment [Data are available via ProteomeXchange with identifer PXD022380]. Te basic principles of low linear energy transfer (LET) ionizing radiation (IR) induced efects on mammalian systems have been broadly explored and there exists comprehensive knowledge on the health efects of high doses of IR delivered at high dose rates.
    [Show full text]
  • Visualization of Human Karyopherin Beta-1/Importin Beta-1 Interactions
    www.nature.com/scientificreports OPEN Visualization of human karyopherin beta-1/importin beta-1 interactions with protein partners in mitotic Received: 28 April 2017 Accepted: 29 December 2017 cells by co-immunoprecipitation Published: xx xx xxxx and proximity ligation assays Laura Di Francesco1,4, Annalisa Verrico2, Italia Anna Asteriti2, Paola Rovella2, Pietro Cirigliano3, Giulia Guarguaglini2, Maria Eugenia Schinin1 & Patrizia Lavia 2 Karyopherin beta-1/Importin beta-1 is a conserved nuclear transport receptor, acting in protein nuclear import in interphase and as a global regulator of mitosis. These pleiotropic functions refect its ability to interact with, and regulate, diferent pathways during the cell cycle, operating as a major efector of the GTPase RAN. Importin beta-1 is overexpressed in cancers characterized by high genetic instability, an observation that highlights the importance of identifying its partners in mitosis. Here we present the frst comprehensive profle of importin beta-1 interactors from human mitotic cells. By combining co-immunoprecipitation and proteome-wide mass spectrometry analysis of synchronized cell extracts, we identifed expected (e.g., RAN and SUMO pathway factors) and novel mitotic interactors of importin beta-1, many with RNA-binding ability, that had not been previously associated with importin beta-1. These data complement interactomic studies of interphase transport pathways. We further developed automated proximity ligation assay (PLA) protocols to validate selected interactors. We succeeded in obtaining spatial and temporal resolution of genuine importin beta-1 interactions, which were visualized and localized in situ in intact mitotic cells. Further developments of PLA protocols will be helpful to dissect importin beta-1-orchestrated pathways during mitosis.
    [Show full text]
  • UBR-Box Containing Protein, UBR5, Is Over-Expressed in Human Lung 2 Adenocarcinoma and Is a Potential Therapeutic Target 3 Authors: Kumar Saurabh1, Parag P
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.03.131912; this version posted June 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 UBR-Box containing protein, UBR5, is over-expressed in human lung 2 adenocarcinoma and is a potential therapeutic target 3 Authors: Kumar Saurabh1, Parag P. Shah1, Mark A. Doll1,2, Leah J. Siskind1,2 and Levi J. 4 Beverly1,2,3,# 5 Affiliations: 6 1James Graham Brown Cancer Center, School of Medicine, University of Louisville, Louisville, 7 KY USA. 8 2Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA. 9 3Division of Hematology and Oncology, School of Medicine, University of Louisville, Louisville, 10 KY, USA. 11 #Corresponding author (Email: [email protected]) 12 13 Abstract 14 Background: N-end rule ubiquitination pathway is known to be disrupted in many diseases, 15 including cancer. UBR5, an E3 ubiquitin ligase, is mutated and/or overexpressed in human lung 16 cancer cells suggesting its pathological role in cancer. 17 Methods: We determined expression of UBR5 protein in multiple lung cancer cell lines and 18 human patient samples. Using immunoprecipitation followed by mass spectrometry we 19 determined the UBR5 interacting proteins. The impact of loss of UBR5 for lung adenocarcinoma 20 cell lines was analyzed using cell viability, clonogenic assays and in vivo xenograft models in 21 nude mice. Additional Western blot analysis was performed to assess the loss of UBR5 on 22 downstream signaling.
    [Show full text]
  • A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre- Clinical Discoveries
    Cancers 2019 S1 of S18 Supplementary Materials: A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre- Clinical Discoveries Danilo Fiore, Luca Vincenzo Cappelli, Paul Zumbo, Jude M. Phillip, Zhaoqi Liu, Shuhua Cheng, Liron Yoffe, Paola Ghione, Federica Di Maggio, Ahmet Dogan, Inna Khodos, Elisa de Stanchina, Joseph Casano, Clarisse Kayembe, Wayne Tam, Doron Betel, Robin Foa’, Leandro Cerchietti, Raul Rabadan, Steven Horwitz, David M. Weinstock and Giorgio Inghirami A B C Figure S1. (A) Histology micrografts on IL89 PDTX show overall similarity between T1 T3 and T7 passages (upper panels). Immunohistochemical stains with the indicated antibodies (anti-CD3, anti- CD25 and anti-CD8 [x20]) (lower panels). (B) Flow cytometry panel comprehensive of the most represented surface T-cell lymphoma markers, including: CD2, CD3, CD4, CD5, CD8, CD16, CD25, CD30, CD56, TCRab, TCRgd. IL89 PDTX passage T3 is here depicted for illustration purposes. (C) Analysis of the TCR gamma specific rearrangement clonality in IL89 diagnostic sample and correspondent PDTX after 1 and 5 passages (T1 and T5). A WT Primary p.G1097D IL89 T1 p.G1097D IL89 T5 p.G1097D IL89 cell line B Figure S2. (A) Sanger sequencing confirms the presence of the JAK1 p.G1097D mutation in IL89 PDTX samples and in the cell line, but the mutation is undetectable in the primary due to the low sensitivity of the technique. (B) Manual backtracking of mutations in the primary tumor using deep sequencing data allowed for the identification of several hits at a very low VAF compared to the PDTX-T5. A B IL89 CTRL 30 CTRL Ruxoli?nib S 20 M Ruxoli?nib A R G 10 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 1 1 1 1 1 WEEKS AFTER ENGRAFTMENT Figure S3.
    [Show full text]
  • UBR5-Mediated Ubiquitination of ATMIN Is Required for Ionizing Radiation-Induced ATM Signaling and Function
    UBR5-mediated ubiquitination of ATMIN is required for ionizing radiation-induced ATM signaling and function Tianyi Zhanga,1, Janet Cronshawa, Nnennaya Kanua,2, Ambrosius P. Snijdersb, and Axel Behrensa,c,3 aMammalian Genetics Laboratory, Cancer Research UK London Research Institute, London WC2A 3LY, United Kingdom; bProtein Analysis and Proteomics Laboratory, Clare Hall Laboratories, Cancer Research UK London Research Institute, South Mimms EN6 3LD, Hertfordshire, United Kingdom; and cSchool of Medicine, Guy’s Campus, King’s College London, London SE1 1UL, United Kingdom Edited by Stephen J. Elledge, Harvard Medical School, Boston, MA, and approved July 3, 2014 (received for review January 6, 2014) The Mre11/Rad50/NBS1 (MRN) protein complex and ATMIN protein receptor (13) and interacts with other proteins such as p53 (14). mediate ATM kinase signaling in response to ionizing radiation (IR) UBR5 has been shown to mediate degradation of several pro- and chromatin changes, respectively. NBS1 and ATMIN directly com- teins, including katanin p60, beta-catenin, TOPBP1, and TERT pete for ATM binding, but the molecular mechanism favoring either protein, the catalytic subunit of telomerase (15–18). UBR5 has NBS1 or ATMIN in response to specific stimuli is enigmatic. Here, we also been implicated in the DNA damage response: it interacts identify the E3 ubiquitin ligase UBR5 as a key component of ATM with Chk2 and is necessary for Chk2 phosphorylation and cell- activation in response to IR. UBR5 interacts with ATMIN and cata- cycle arrest in response to IR (19, 20). More recently, UBR5, lyzes ubiquitination of ATMIN at lysine 238 in an IR-stimulated man- together with another E3 ubiquitin ligase, Trip12, has been shown ner, which decreases ATMIN interaction with ATM and promotes to restrict histone ubiquitination and p53-binding protein 1 MRN-mediated signaling.
    [Show full text]
  • Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
    cells Review Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss 1, 1, 1 1,2,3 1 Gayle B. Collin y, Navdeep Gogna y, Bo Chang , Nattaya Damkham , Jai Pinkney , Lillian F. Hyde 1, Lisa Stone 1 , Jürgen K. Naggert 1 , Patsy M. Nishina 1,* and Mark P. Krebs 1,* 1 The Jackson Laboratory, Bar Harbor, Maine, ME 04609, USA; [email protected] (G.B.C.); [email protected] (N.G.); [email protected] (B.C.); [email protected] (N.D.); [email protected] (J.P.); [email protected] (L.F.H.); [email protected] (L.S.); [email protected] (J.K.N.) 2 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 3 Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand * Correspondence: [email protected] (P.M.N.); [email protected] (M.P.K.); Tel.: +1-207-2886-383 (P.M.N.); +1-207-2886-000 (M.P.K.) These authors contributed equally to this work. y Received: 29 February 2020; Accepted: 7 April 2020; Published: 10 April 2020 Abstract: Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal models, particularly the laboratory mouse, have been used to understand the pathogenic mechanisms that underlie PR cell loss and to explore therapies that may prevent, delay, or reverse RD. Here, we reviewed entries in the Mouse Genome Informatics and PubMed databases to compile a comprehensive list of monogenic mouse models in which PR cell loss is demonstrated.
    [Show full text]
  • An Integrative Genomic Analysis of the Longshanks Selection Experiment for Longer Limbs in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: 2 An integrative genomic analysis of the Longshanks selection experiment for longer limbs in mice 3 Short Title: 4 Genomic response to selection for longer limbs 5 One-sentence summary: 6 Genome sequencing of mice selected for longer limbs reveals that rapid selection response is 7 due to both discrete loci and polygenic adaptation 8 Authors: 9 João P. L. Castro 1,*, Michelle N. Yancoskie 1,*, Marta Marchini 2, Stefanie Belohlavy 3, Marek 10 Kučka 1, William H. Beluch 1, Ronald Naumann 4, Isabella Skuplik 2, John Cobb 2, Nick H. 11 Barton 3, Campbell Rolian2,†, Yingguang Frank Chan 1,† 12 Affiliations: 13 1. Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany 14 2. University of Calgary, Calgary AB, Canada 15 3. IST Austria, Klosterneuburg, Austria 16 4. Max Planck Institute for Cell Biology and Genetics, Dresden, Germany 17 Corresponding author: 18 Campbell Rolian 19 Yingguang Frank Chan 20 * indicates equal contribution 21 † indicates equal contribution 22 Abstract: 23 Evolutionary studies are often limited by missing data that are critical to understanding the 24 history of selection. Selection experiments, which reproduce rapid evolution under controlled 25 conditions, are excellent tools to study how genomes evolve under strong selection. Here we 1 bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018.
    [Show full text]